
To report the detection of secondary neurotransmitter abnormalities in a group of zzso patients and describe treatment with zzso and zzso 

Case zzso 

National Institutes of Health in the zzso Disease zzso Children's National Medical Center in the zzso Disorders zzso zzso 

Four zzso patients with a clinical picture of progressive zzso zzso complicated by zzso symptoms and zzso 

zzso and zzso 

3/4 patients presented secondary neurotransmitter zzso zzso partially responded to L-dopa as well as zzso 

In the zzso patient with zzso symptoms, a trial of zzso and zzso and/or evaluation of zzso fluid zzso should be zzso 

